News on Carboplatin from BioPortfolio.com http://www.BioPortfolio.com Consolidated Carboplatin news from BioPortfolio.com Wed, 10 Feb 2010 09:04:15 GMT en A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028713&HITNO=0&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028713&THISHREF=http://c.moreover.com/click/here.pl%3fz2532827041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028713&HITNO=0&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028713&THISHREF=http://c.moreover.com/click/here.pl%3fz2532827041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: TopoTarget signs co-development and commercialization agreement with Spectrum Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022677&HITNO=1&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022677&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4022677&HITNO=1&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4022677&THISHREF=http://c.moreover.com/click/here.pl%3fz2527794765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: TopoTarget Partner, Spectrum Pharmaceuticals, to host Conference Call Thursday 4 February 2010 at 19:00 CET (1http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=2&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018412&HITNO=2&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018412&THISHREF=http://c.moreover.com/click/here.pl%3fz2525657571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: TopoTarget Partner, Spectrum Pharmaceuticals, to host Conference Call Thursday 4 February 2010 at 19:00 CET (1http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014950&HITNO=3&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014950&THISHREF=http://c.moreover.com/click/here.pl%3fz2524222295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014950&HITNO=3&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014950&THISHREF=http://c.moreover.com/click/here.pl%3fz2524222295%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011630&HITNO=4&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011630&THISHREF=http://c.moreover.com/click/here.pl%3fz2523025591%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011630&HITNO=4&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011630&THISHREF=http://c.moreover.com/click/here.pl%3fz2523025591%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Spectrum Pharmaceuticals Licenses Belinostat, A Novel Anticancer Drug In A Pivotal Registrational Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011428&HITNO=5&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011428&THISHREF=http://c.moreover.com/click/here.pl%3fz2522922252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011428&HITNO=5&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011428&THISHREF=http://c.moreover.com/click/here.pl%3fz2522922252%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Spectrum Pharmaceuticals Licenses Belinostat, A Novel Anticancer Drug In A Pivotal Registrational Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011425&HITNO=6&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011425&THISHREF=http://c.moreover.com/click/here.pl%3fz2522921510%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011425&HITNO=6&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011425&THISHREF=http://c.moreover.com/click/here.pl%3fz2522921510%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Spectrum Pharma licenses lymphoma drug belinostat from TopoTarget for up to $350 millionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009779&HITNO=7&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009779&THISHREF=http://c.moreover.com/click/here.pl%3fz2522089384%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009779&HITNO=7&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009779&THISHREF=http://c.moreover.com/click/here.pl%3fz2522089384%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: Spectrum buys cancer pipeline for $350 mnhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003442&HITNO=8&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003442&THISHREF=http://c.moreover.com/click/here.pl%3fz2519503480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003442&HITNO=8&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003442&THISHREF=http://c.moreover.com/click/here.pl%3fz2519503480%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996435&HITNO=9&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996435&THISHREF=http://c.moreover.com/click/here.pl%3fz2516296889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3996435&HITNO=9&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3996435&THISHREF=http://c.moreover.com/click/here.pl%3fz2516296889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOncology: Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000314&HITNO=10&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000314&THISHREF=http://c.moreover.com/click/here.pl%3fz2517960158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000314&HITNO=10&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000314&THISHREF=http://c.moreover.com/click/here.pl%3fz2517960158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000013&HITNO=11&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000013&THISHREF=http://c.moreover.com/click/here.pl%3fz2517784705%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000013&HITNO=11&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000013&THISHREF=http://c.moreover.com/click/here.pl%3fz2517784705%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Spectrum Pharmaceuticals, Inc. (SPPI) Licenses Belinostat from TopoTarget A/S for $http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999767&HITNO=12&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999767&THISHREF=http://c.moreover.com/click/here.pl%3fz2517637986%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999767&HITNO=12&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999767&THISHREF=http://c.moreover.com/click/here.pl%3fz2517637986%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Spectrum and Topotargethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999463&HITNO=13&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999463&THISHREF=http://c.moreover.com/click/here.pl%3fz2517449323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999463&HITNO=13&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999463&THISHREF=http://c.moreover.com/click/here.pl%3fz2517449323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Spectrum Pharmaceuticals, Inc. (SPPI) Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrationalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999161&HITNO=14&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999161&THISHREF=http://c.moreover.com/click/here.pl%3fz2517341733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999161&HITNO=14&MSIZE=118&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Carboplatin&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999161&THISHREF=http://c.moreover.com/click/here.pl%3fz2517341733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: